A deep learning framework for predicting the neutralizing activity of COVID-19 therapeutics and vaccines against evolving SARS-CoV-2 variants
R. P. Matson, I. Y. Comba, E. Silvert, M. J. Niesen, K. Murugadoss, D. Padwardhan, R. Suratekar, E.-G. Goel, B. J. Poelaert, K. Wan, K. R. Brimacombe, A. Venkatakrishnan, V. Soundararajan
This paper develops a deep learning model to predict neutralizing activity of COVID-19 therapeutics and vaccines against SARS-CoV-2 variants, finding reduced activity against newer variants like EG.5 and XBB.1.16.
bioRxiv · Oct 24, 2023 · PreprintImmunology